ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type | Year |
State |
|---|---|---|---|---|
| Inflammatory Signaling in the Tumor Microenvironment | St. Jude Children's Research Hospital / Peter J. Murray, PhD | Springboard Grants | 2013 | Tennessee |
| Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease | St. Jude Children's Research Hospital / Linda Hendershot, PhD | Innovation Grants | 2019 | Tennessee |
| Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment | Vanderbilt University Medical Center / John Wilson, PhD | 'A' Award Grants | 2015 | Tennessee |
| Small Molecule Degraders for Targeting Transcription Factor Drivers of Childhood Cancers | St. Jude Children's Research Hospital / Charles G. Mullighan, MBBS(Hons), MSc, MD, FRACP, FRCPA | Crazy 8 Awards | 2021 | Tennessee |
| Describing the Biological Impacts of Gain-of-function SAMD9 Mutations | Vanderbilt University Medical Center / Jason Schwartz, MD/PhD | Young Investigator Grants | 2018 | Tennessee |
| NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia | St. Jude Children's Research Hospital / Takaya Moriyama, MD/PhD | Young Investigator Grants | 2018 | Tennessee |
| Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia | St. Jude Children's Research Hospital / Charles Mullighan, MD | Innovation Grants | 2019 | Tennessee |
| CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors | St. Jude Children's Research Hospital / Stephen Gottschalk, MD & Nino Rainusso, MD | Innovation Grants | 2016 | Tennessee |
| Novel Targeted Therapies for Rhabdomyosarcoma | St. Jude Children's Research Hospital / Michael Dyer, PhD | Innovation Grants | 2013 | Tennessee |
| MYC as a Driver and Anti-Cancer Target in Malignant Rhabdoid Tumors | Vanderbilt University Medical Center / William Tansey, PhD | Innovation Grants | 2016 | Tennessee |